5A2S | pdb_00005a2s

Potent, selective and CNS-penetrant tetrasubstituted cyclopropane class IIa histone deacetylase (HDAC) inhibitors


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.65 Å
  • R-Value Free: 
    0.256 (Depositor), 0.251 (DCC) 
  • R-Value Work: 
    0.185 (Depositor), 0.188 (DCC) 
  • R-Value Observed: 
    0.189 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 5A2S

Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history

Literature

Potent, Selective, and Cns-Penetrant Tetrasubstituted Cyclopropane Class Iia Histone Deacetylase (Hdac) Inhibitors.

Luckhurst, C.A.Breccia, P.Stott, A.J.Aziz, O.Birch, H.L.Burli, R.W.Hughes, S.J.Jarvis, R.E.Lamers, M.Leonard, P.M.Matthews, K.L.Mcallister, G.Pollack, S.Saville-Stones, E.Wishart, G.Yates, D.Dominguez, C.

(2016) ACS Med Chem Lett 7: 34

  • DOI: https://doi.org/10.1021/acsmedchemlett.5b00302
  • Primary Citation Related Structures: 
    5A2S

  • PubMed Abstract: 

    Potent and selective class IIa HDAC tetrasubstituted cyclopropane hydroxamic acid inhibitors were identified with high oral bioavailability that exhibited good brain and muscle exposure. Compound 14 displayed suitable properties for assessment of the impact of class IIa HDAC catalytic site inhibition in preclinical disease models.


  • Organizational Affiliation
    • BioFocus, Charles River , Chesterford Research Park, Saffron Walden, Essex, CB10 1XL, United Kingdom.

Macromolecule Content 

  • Total Structure Weight: 86.55 kDa 
  • Atom Count: 5,783 
  • Modeled Residue Count: 760 
  • Deposited Residue Count: 790 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
HISTONE DEACETYLASE 4
A, B
395Homo sapiensMutation(s): 1 
EC: 3.5.1.98
UniProt & NIH Common Fund Data Resources
Find proteins for P56524 (Homo sapiens)
Explore P56524 
Go to UniProtKB:  P56524
PHAROS:  P56524
GTEx:  ENSG00000068024 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP56524
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 3 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
OTF

Query on OTF



Download:Ideal Coordinates CCD File
C [auth A],
G [auth B]
(1S,2S,3S)-1-fluoranyl-2-[4-(5-fluoranylpyrimidin-2-yl)phenyl]-N-oxidanyl-3-phenyl-cyclopropane-1-carboxamide
C20 H15 F2 N3 O2
MREATSZIGJDNKB-HLIPFELVSA-N
ZN

Query on ZN



Download:Ideal Coordinates CCD File
D [auth A],
E [auth A],
H [auth B],
I [auth B]
ZINC ION
Zn
PTFCDOFLOPIGGS-UHFFFAOYSA-N
NA

Query on NA



Download:Ideal Coordinates CCD File
F [auth A],
J [auth B]
SODIUM ION
Na
FKNQFGJONOIPTF-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.65 Å
  • R-Value Free:  0.256 (Depositor), 0.251 (DCC) 
  • R-Value Work:  0.185 (Depositor), 0.188 (DCC) 
  • R-Value Observed: 0.189 (Depositor) 
Space Group: P 2 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 52.948α = 90
b = 82.141β = 90
c = 161.626γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
XDSdata reduction
SCALAdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Revision History  (Full details and data files)

  • Version 1.0: 2016-02-10
    Type: Initial release
  • Version 1.1: 2024-01-10
    Changes: Data collection, Database references, Derived calculations, Other, Refinement description